Deerfield Mgmt L.P.'s Net Worth

$406 Million

Who is Deerfield Mgmt L.P.?

Deerfield Mgmt L.P. has an estimated net worth of $406 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Dicerna Pharmaceuticals Inc, Invuity, Inc., DYNAVAX TECHNOLOGIES CORP, XERIS PHARMACEUTICALS INC, ARENA PHARMACEUTICALS INC, Invitae Corp, Auspex Pharmaceuticals, Inc., Fibrocell Science, Inc., TriVascular Technologies, Inc., REGENXBIO Inc., CONSTELLATION PHARMACEUTICALS INC, NeurogesX Inc, Oncology Institute, Inc., Nkarta, Inc., Revolution Medicines, Inc., Kiniksa Pharmaceuticals, Ltd., DA32 Life Science Tech Acquisition Corp., RIGEL PHARMACEUTICALS INC, eHealth, Inc., Singular Genomics Systems, Inc., Nivalis Therapeutics, Inc., Deerfield Healthcare Technology Acquisitions Corp., Shockwave Medical, Inc., Aclaris Therapeutics, Inc., Vanda Pharmaceuticals Inc., Generation Bio Co., ANTARES PHARMA, INC., AERIE PHARMACEUTICALS INC, AVADEL PHARMACEUTICALS PLC, Axogen, Inc., ARVINAS INC., Neos Therapeutics, Inc., Loxo Oncology, Inc., NeuroMetrix, Inc., Mirum Pharmaceuticals, Inc., GRAYBUG VISION, INC., Acutus Medical, Inc., Xilio Therapeutics, Inc., Larimar Therapeutics, Inc., Terns Pharmaceuticals, Inc., Cyclacel Pharmaceuticals, Inc., Syros Pharmaceuticals, Inc., Recro Pharma, Inc., CATALYST BIOSCIENCES, INC., CytomX Therapeutics, Inc., Mallinckrodt plc, CAS MEDICAL SYSTEMS INC, PROTEON THERAPEUTICS INC, AveXis, Inc., SteadyMed Ltd., Cabaletta Bio, Inc., Annexon, Inc., aTYR PHARMA INC, ALIMERA SCIENCES INC, Black Diamond Therapeutics, Inc., Ignyte Acquisition Corp., Werewolf Therapeutics, Inc., STREAMLINE HEALTH SOLUTIONS INC., Frequency Therapeutics, Inc., Oncorus, Inc., Audentes Therapeutics, Inc., AUXILIUM PHARMACEUTICALS INC, Talon Therapeutics, Inc., NxStage Medical, Inc., PepGen Inc., HI TECH PHARMACAL CO INC, DUSA PHARMACEUTICALS INC, PAR PHARMACEUTICAL COMPANIES, INC., Frazier Lifesciences Acquisition Corp, Nuvalent, Inc., ANADYS PHARMACEUTICALS INC, XENOPORT INC, ISTA PHARMACEUTICALS INC, Somaxon Pharmaceuticals, Inc., SALIX PHARMACEUTICALS LTD, MEDICINES CO /DE, NITROMED INC, VIA Pharmaceuticals, Inc., EMAGEON INC, THIRD WAVE TECHNOLOGIES INC /WI, INSPIRE PHARMACEUTICALS INC, Homology Medicines, Inc., Avalanche Biotechnologies, Inc., Schrodinger, Inc., and FISCHER IMAGING CORP.

SEC CIK

Deerfield Mgmt L.P.'s CIK is 0001010823

Past Insider Trading and Trends

2006 was Deerfield Mgmt L.P.'s most active year for acquiring shares with 128 total transactions. Deerfield Mgmt L.P.'s most active month to acquire stocks was the month of June. 2011 was Deerfield Mgmt L.P.'s most active year for disposing of shares, totalling 196 transactions. Deerfield Mgmt L.P.'s most active month to dispose stocks was the month of May. 2021 saw Deerfield Mgmt L.P. paying a total of $333,020,601.60 for 41,576,324 shares, this is the most they've acquired in one year. In 2020 Deerfield Mgmt L.P. cashed out on 87,434,254 shares for a total of $18,052,380.80, their largest year based on trade value.